Apotex and Arrow agree merger of Australian and New Zealand operations
11 May 2018 -

Apotex Australia, an affiliate of privately owned Canadian pharmaceutical company Apotex Inc, has agreed to combine its Australian and New Zealand generic pharmaceutical and over-the-counter (OTC) operations with Arrow Pharmaceuticals, the company announced on Wednesday.

Arrow Pharmaceuticals Pty Ltd is the Australian operating business of India-based pharmaceutical company Strides (BSE: 532531). It markets more than 180 generic pharmaceutical products, as well as a pharmacy-only OTC products range under the Chemist's Own brand, to pharmacies across Australia.

When completed, the merged company will offer pharmacists, patients and consumers a diverse range of almost 500 products.

The merger remains subject to several conditions, including approval from the Australian Competition and Consumer Commission (ACCC) and due diligence.